Villere ST Denis J & Co. LLC Buys Shares of 681,540 Kenvue Inc. $KVUE

Villere ST Denis J & Co. LLC bought a new position in Kenvue Inc. (NYSE:KVUE) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 681,540 shares of the company’s stock, valued at approximately $11,061,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. QRG Capital Management Inc. boosted its position in Kenvue by 188.3% in the second quarter. QRG Capital Management Inc. now owns 45,645 shares of the company’s stock valued at $955,000 after buying an additional 29,813 shares in the last quarter. Clarius Group LLC lifted its stake in shares of Kenvue by 34.1% in the 2nd quarter. Clarius Group LLC now owns 12,158 shares of the company’s stock valued at $254,000 after acquiring an additional 3,090 shares during the last quarter. Simplicity Wealth LLC bought a new position in Kenvue in the second quarter valued at about $507,000. DAVENPORT & Co LLC boosted its stake in shares of Kenvue by 2.9% during the second quarter. DAVENPORT & Co LLC now owns 392,019 shares of the company’s stock valued at $8,196,000 after purchasing an additional 11,122 shares in the last quarter. Finally, Valeo Financial Advisors LLC grew its holdings in shares of Kenvue by 7.6% during the second quarter. Valeo Financial Advisors LLC now owns 15,868 shares of the company’s stock worth $332,000 after purchasing an additional 1,127 shares during the last quarter. 97.64% of the stock is owned by institutional investors.

Insider Transactions at Kenvue

In related news, Director Jeffrey C. Smith acquired 3,200,000 shares of the firm’s stock in a transaction on Friday, December 12th. The stock was purchased at an average cost of $17.37 per share, with a total value of $55,584,000.00. Following the acquisition, the director owned 27,307,632 shares of the company’s stock, valued at approximately $474,333,567.84. This trade represents a 13.27% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Company insiders own 0.17% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the stock. JPMorgan Chase & Co. dropped their price objective on shares of Kenvue from $24.00 to $21.00 and set an “overweight” rating for the company in a report on Friday, October 10th. Johnson Rice restated a “neutral” rating on shares of Kenvue in a research report on Tuesday, October 28th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Kenvue in a report on Friday, January 9th. Barclays increased their price objective on Kenvue from $17.00 to $18.00 and gave the company an “equal weight” rating in a report on Monday, November 10th. Finally, Zacks Research upgraded Kenvue from a “strong sell” rating to a “hold” rating in a research report on Wednesday, November 26th. One analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and thirteen have issued a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $19.90.

Kenvue Stock Down 0.1%

KVUE stock opened at $17.39 on Tuesday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 0.98. Kenvue Inc. has a fifty-two week low of $14.02 and a fifty-two week high of $25.17. The stock’s 50 day simple moving average is $17.18 and its 200 day simple moving average is $17.96. The company has a market cap of $33.31 billion, a P/E ratio of 23.18 and a beta of 0.59.

Kenvue (NYSE:KVUE) last announced its quarterly earnings results on Monday, November 3rd. The company reported $0.28 EPS for the quarter, beating analysts’ consensus estimates of $0.27 by $0.01. Kenvue had a net margin of 9.55% and a return on equity of 20.02%. The business had revenue of $3.76 billion during the quarter, compared to analyst estimates of $3.83 billion. During the same quarter in the previous year, the business posted $0.28 EPS. Kenvue’s quarterly revenue was down 3.5% on a year-over-year basis. On average, research analysts expect that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, February 25th. Investors of record on Wednesday, February 11th will be given a $0.2075 dividend. The ex-dividend date of this dividend is Wednesday, February 11th. This represents a $0.83 annualized dividend and a yield of 4.8%. Kenvue’s dividend payout ratio (DPR) is presently 110.67%.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.